For biomedical industry, partial government shutdown a New Year’s headache

As a partial government shutdown drags on, biomedical researchers and companies are looking at 2019 with anxiety.

Researchers who plan to apply for grants from the National Institutes of Health and companies seeking product approval from the U.S. Food and Drug Administration worry that the shutdown…

Click to view original post